V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250010706 | 250007909 | null | 81 | Palliative (P) | 2017-12-14 | 2017-12-16 | AML18 PILOT TRIAL | 02 | N | 250031855 | CARBOPLATIN + PACLITAXEL |
| 250010707 | 250007911 | 1.55 | 84 | Palliative (P) | 2017-12-19 | 2018-01-17 | Rituximab | N | N | 250031856 | BEVACIZUMAB |
| 250010708 | 250007911 | 1.63 | 90 | Palliative (P) | 2013-12-29 | 2013-12-29 | Carboplatin AUC 6 - 10 | 01 | N | 250031856 | NOT MATCHED |
| 250010710 | 250007914 | 1.74 | 49.8 | Palliative (P) | 2014-08-10 | 2014-08-10 | CARBOPLATIN + VINORELBINE | N | N | 250031889 | CISPLATIN + VINORELBINE |
| 250010711 | 250007916 | 1.64 | 80 | Palliative (P) | 2014-02-08 | 2014-02-08 | Azacitidine | 02 | N | 250031889 | IPM |
| 250010712 | 250012137 | null | null | Palliative (P) | 2014-01-29 | 2014-01-29 | TEMOZOLOMIDE | N | N | 250031903 | IPM |
| 250010713 | 250007917 | 1.68 | null | Palliative (P) | 2013-09-17 | 2013-10-03 | Busulfan Oral | 02 | N | 250031906 | AZACITIDINE |
| 250010714 | 250007918 | null | null | Palliative (P) | 2018-11-22 | 2018-12-20 | IPM | N | N | 250031907 | IPM |
| 250010715 | 250010951 | 1.5 | 143 | Palliative (P) | 2016-05-12 | 2016-05-24 | BUSULFAN | N | N | 250031907 | METHOTREXATE INTRATHECAL |
| 250010716 | 250012602 | 1.62 | 67.8 | Palliative (P) | 2015-10-25 | 2015-12-06 | Azacitidine | N | N | 250031914 | METHOTREXATE INTRATHECAL |
| 250010717 | 250012602 | 1.74 | 72 | Palliative (P) | 2017-02-26 | 2017-02-26 | GDP | 02 | N | 250031914 | BORTEZOMIB |
| 250010719 | 250010953 | 1.65 | 62.4 | Palliative (P) | 2014-11-26 | 2014-11-26 | Carboplatin + Vinorelbine IV | 2 | N | 250031917 | CETUXIMAB + IRINOTECAN + MDG |
| 250010720 | 250012799 | 1.66 | 71 | Palliative (P) | 2014-01-06 | 2014-01-06 | IPM | N | N | 250031930 | IPM |
| 250010721 | 250007922 | null | null | Palliative (P) | 2015-07-02 | 2015-07-03 | DA 3 + 10 | Y | N | 250031931 | AZACITIDINE |
| 250010722 | 250007923 | 1.66 | 101 | Palliative (P) | 2016-03-15 | 2016-04-12 | BUSULFAN | 02 | N | 250031935 | CARBOPLATIN + VINORELBINE |
| 250010723 | 250010956 | 1.68 | 83.8 | Palliative (P) | 2014-10-16 | 2015-01-08 | GemCarbo Days 1+8 | 99 | null | 250031941 | ATG + BUSULFAN + FLUDARABINE |
| 250010724 | 250010956 | 0 | 74.6 | Palliative (P) | 2015-01-22 | 2015-01-23 | GemCarbo Days 1+8 | N | N | 250031941 | GEMCARBO |
| 250010725 | 250007925 | 1.59 | 58.3 | Disease modification (D) | 2014-05-21 | 2014-07-09 | BUSULFAN | N | N | 250031948 | AFLIBERCEPT + FU + IRINOTECAN |
| 250010728 | 250007929 | 1.79 | 62.1 | Adjuvant (A) | null | 2018-06-29 | GEMCITABINE | N | N | 250031957 | GEMCARBO |
| 250010729 | 250007930 | 1.52 | 83.7 | Palliative (P) | 2014-06-30 | 2014-07-03 | BUSULFAN | N | N | 250031957 | PEMBROLIZUMAB |
| 250010730 | 250012141 | 1.52 | 66 | Palliative (P) | 2016-06-12 | 2016-06-12 | Eribulin | N | N | 250031960 | PEMBROLIZUMAB |
| 250010731 | 250007931 | 1.77 | 74 | Palliative (P) | 2018-05-07 | 2018-05-07 | IPM | 01 | N | 250031978 | PAD |
| 250010732 | 250007931 | 1.62 | null | Palliative (P) | 2015-01-21 | 2015-02-14 | BENDAMUSTINE + RITUXIMAB | N | N | 250031978 | IMATINIB |
| 250010733 | 250007932 | null | 57 | null | 2017-07-13 | 2017-07-13 | Pemetrexed | null | null | 250031985 | IPM |
| 250010734 | 250007933 | 1.56 | 51.8 | Palliative (P) | 2014-05-14 | 2014-05-28 | PAD | N | N | 250031988 | NOT MATCHED |
| 250010735 | 250007936 | 1.69 | 149 | null | 2014-10-17 | 2014-10-19 | Docetaxel 75mg/m2 (21 day) | N | N | 250031990 | ENZALUTAMIDE |
| 250010736 | 250007937 | 1.52 | 62.6 | Palliative (P) | 2012-09-13 | 2016-01-22 | Busulfan Oral | null | N | 250031999 | GEMCARBO |
| 250010737 | 250010962 | 1.65 | 0 | null | 2017-01-27 | 2017-02-17 | IPM | 02 | N | 250032009 | IRINOTECAN + MDG |
| 250010738 | 250007939 | 1.64 | 91 | Palliative (P) | 2014-03-21 | 2014-04-26 | Busulfan Oral | N | N | 250032011 | CARBOPLATIN + PACLITAXEL |
| 250010739 | 250007940 | 1.65 | 45.5 | Palliative (P) | null | 2014-09-05 | R GCVP | null | N | 250032027 | GEMCARBO |
| 250010740 | 250007941 | 1.78 | 90 | Palliative (P) | 2016-03-29 | 2016-07-05 | CARBOPLATIN + PACLITAXEL | 2 | N | 250032028 | CARBOPLATIN + PACLITAXEL |
| 250010741 | 250007941 | 1.71 | 69 | Palliative (P) | 2017-05-12 | 2017-05-16 | null | 02 | N | 250032028 | CISPLATIN + GEMCITABINE |
| 250010742 | 250012144 | 1.59 | 69 | Palliative (P) | 2015-08-11 | 2015-08-23 | Pemetrexed | 02 | N | 250032031 | CARBOPLATIN + VINORELBINE |
| 250010743 | 250012800 | null | 85.7 | Adjuvant (A) | 2015-11-15 | 2018-04-15 | COMMAND trial | N | N | 250032036 | GEMCARBO |
| 250010744 | 250012800 | 1.82 | 96 | null | 2014-02-25 | 2014-03-14 | Busulfan Oral | 2 | N | 250032036 | GEMCARBO |
| 250010745 | 250012800 | 0 | 66 | Palliative (P) | 2016-02-20 | 2016-03-01 | GEMCARBO | 2 | N | 250032036 | CARBOPLATIN + PACLITAXEL |
| 250010746 | 250007944 | 1.65 | 67.4 | Disease modification (D) | null | 2018-01-19 | CVP R | N | N | 250032041 | BUSULPHAN |
| 250010747 | 250007944 | null | null | Palliative (P) | 2014-11-26 | 2014-11-26 | BUSULFAN | 02 | N | 250032041 | CYTARABINE |
| 250010748 | 250012606 | null | 25.4 | Disease modification (D) | 2018-07-12 | 2018-08-21 | BUSULFAN | Y | null | 250032056 | GEMCITABINE |
| 250010749 | 250007945 | null | null | Curative (C) | 2016-02-13 | 2016-02-22 | CARBOPLATIN | 2 | N | 250032071 | CISPLATIN + PACLITAXEL |
| 250010752 | 250007950 | null | 66 | Adjuvant (A) | 2013-07-21 | 2013-09-10 | Capecitabine | 2 | N | 250032084 | IPM |
| 250010753 | 250007951 | 1.7 | 98.7 | Palliative (P) | 2018-03-12 | 2018-03-14 | GemCarbo Days 1+8 | 02 | N | 250032099 | COMMAND TRIAL |
| 250010754 | 250007952 | 1.52 | 96.4 | Curative (C) | 2015-11-09 | 2015-12-12 | PACLITAXEL | N | N | 250032100 | COMMAND TRIAL |
| 250010755 | 250007953 | 1.79 | 81.9 | Disease modification (D) | 2017-09-08 | 2017-09-08 | Carboplatin + Vinorelbine IV | N | N | 250032110 | GEMCARBO |
| 250010756 | 250007954 | 1.62 | 67.8 | Palliative (P) | 2013-12-22 | 2013-12-22 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 250032113 | PAZOPANIB |
| 250010757 | 250007955 | 1.83 | 81.4 | Palliative (P) | null | 2014-05-28 | BENDAMUSTINE + RITUXIMAB | 2 | N | 250032114 | IPM |
| 250010758 | 250007958 | 1.75 | null | Curative (C) | 2013-12-18 | 2013-12-18 | IPM | null | N | 250032117 | GEMCARBO |
| 250010759 | 250007960 | 1.52 | 85.4 | Palliative (P) | 2015-11-08 | 2015-12-05 | Imatinib 400mg | 2 | N | 250032131 | IGEV |
| 250010760 | 250007961 | null | 60.5 | Curative (C) | 2015-06-08 | 2015-06-11 | GemCarbo Days 1+8 | N | N | 250032145 | GEMCARBO |
| 250010761 | 250007962 | null | 96 | Disease modification (D) | 2012-09-29 | 2014-02-07 | Cytarabine Low Dose | null | Y | 250032147 | GEMCARBO |